ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

ClinicalTrials.gov ID: NCT00829374

Public ClinicalTrials.gov record NCT00829374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CONCERT: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients With Mild-to-Moderate Alzheimer's Disease on Donepezil

Study identification

NCT ID
NCT00829374
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Medivation, Inc.
Industry
Enrollment
1,003 participants

Conditions and interventions

Interventions

  • Dimebon Drug
  • Placebo comparator Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2009
Primary completion
Nov 30, 2011
Completion
Nov 30, 2011
Last update posted
Sep 26, 2016

2009 – 2011

United States locations

U.S. sites
52
U.S. states
24
U.S. cities
52
Facility City State ZIP Site status
Not listed Phoenix Arizona 85006
Not listed Sun City Arizona 85351
Not listed Tucson Arizona 85724
Not listed Costa Mesa California 92626
Not listed Encino California 91316
Not listed Escondido California 92025
Not listed Fresno California 93720
Not listed Garden Grove California 92845
Not listed La Jolla California 92037
Not listed Los Alamitos California 90720
Not listed Los Angeles California 90095
Not listed Martinez California 94553
Not listed Newport California 92660
Not listed Paramount California 90723
Not listed Pasadena California 91105
Not listed San Diego California 92103
Not listed San Francisco California 94143
Not listed Boulder Colorado 80304
Not listed Denver Colorado 80218
Not listed New Haven Connecticut 06510
Not listed Washington D.C. District of Columbia 20057
Not listed Deerfield Beach Florida 33064
Not listed Delray Beach Florida 33445
Not listed Jacksonville Florida 32224
Not listed Miami Florida 33137
Not listed Orlando Florida 32806
Not listed Atlanta Georgia 30329
Not listed Honolulu Hawaii 96814
Not listed Indianapolis Indiana 46260
Not listed Lexington Kentucky 40536
Not listed Eaton Maryland 21601
Not listed Boston Massachusetts 02118
Not listed Ann Arbor Michigan 48105
Not listed Las Vegas Nevada 89106
Not listed Mount Arlington New Jersey 07865
Not listed Princeton New Jersey 08540
Not listed Albany New York 12208
Not listed Cedarhurst New York 11516
Not listed New York New York 10029
Not listed Rochester New York 14620
Not listed Durham North Carolina 27710
Not listed Beachwood Ohio 44122
Not listed Toledo Ohio 43623
Not listed Jenkintown Pennsylvania 19046
Not listed Norristown Pennsylvania 19401
Not listed Providence Rhode Island 02906
Not listed Austin Texas 78757
Not listed Houston Texas 77030
Not listed San Antonio Texas 78229
Not listed Charlottesville Virginia 22903
Not listed Seattle Washington 98108
Not listed Middleton Wisconsin 53562

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00829374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2016 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00829374 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →